Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is expected to experience steady earnings growth, with projections of GAAP earnings reaching $4.73 per diluted share in 2025 and $5.17 in 2026, reflecting ongoing strength in the Human Nutrition and Health segment. The company's second quarter of 2025 demonstrated a slight revenue increase to $255.5 million, surpassing expectations and showing consistency compared to previous quarters and the prior year. Additionally, improvements in gross and net margins are anticipated, alongside a potential pathway to becoming debt-free by the end of 2025, which positions the company favorably for future growth and possible mergers and acquisitions.

Bears say

The financial outlook for Balchem Corp appears bleak due to a decline in the applicable P/E multiple, which has dropped from 39.6x to 37.9x, indicating weakening investor confidence and a sluggish performance in revenue and earnings relative to its comparables. Additionally, the company's most recent quarterly results revealed sales in the Animal Nutrition and Health segment missed estimates by approximately $3.6 million, while the Industrial Products segment also fell short by $200,000, suggesting ongoing struggles in achieving growth targets. Furthermore, several identified risks, including slower-than-anticipated business growth, inflationary pressures, and potential disruptions from regional conflicts, compound the negative sentiment surrounding Balchem's financial stability and future performance.

Balchem (BCPC) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Balchem (BCPC) has a Strong Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $190, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $190, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.